StockWatch
·
Specialty Chemicals
Quarterly Result26 May 2026, 05:01 pm

Camlin Fine Sciences: FY26 Revenue ₹1628.69 Mn

AI Summary

Camlin Fine Sciences Ltd's board approved the audited financial results for the year ended March 31, 2026. Consolidated revenue from operations stood at ₹1628.69 million. The board also approved the appointment of M/s. ABK & Associates as Cost Auditors and M/s. Mahajan & Aibara as Internal Auditors for the financial year ending March 31, 2027. Mr. Pankaj Pandey was appointed as CFO, effective August 18, 2026, while Mr. Santosh Parab will be re-designated as President – Strategy and Global CFO.

Key Highlights

  • Audited financial results for FY26 approved with unmodified auditor's opinion.
  • Consolidated revenue from operations for FY26 is ₹1628.69 million.
  • Pankaj Pandey appointed as CFO effective August 18, 2026.
  • Santosh Parab re-designated as President – Strategy and Global CFO from August 18, 2026.
  • ABK & Associates and Mahajan & Aibara appointed as Cost and Internal Auditors respectively.